MarginsXMarginsX
Home › Markets › Health Care › EMBC

Embecta Corp. (EMBC)

EMBC trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$6.25
-3.25% on the day
Market cap
$354.1M
Small cap
Revenue · 2025
$1.1B
-3.8% on 2024
Net income · 2025
$95.4M
8.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-09-30, https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/0001872789-25-000036-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-09-30.

Profile

FieldValue
TickerEMBC on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001872789
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.1B
Net income$95.4M
Operating income$242.1M
Net margin8.8%
Operating margin22.4%
Revenue growth-3.8%
Cash$225.5M
Total assets$1.1B
P/E (computed)3.7×
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$214.7M cash at June 30, 2026
Share count, 1 year
-3.1%
2025-08-01 to 2026-07-31 · -1.1% over 3 years
Going-concern doubt
No
10-Q filed August 7, 2026
Insider net buying, 12 months
$521K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-07
Cash and burn$214.7M cash; operating cash flow $43.5M a quarter.Report 2026-06-30
Shares outstanding56,659,599 (2026-07-31); 58,485,119 a year earlier; 57,303,556 three years earlier.Cover page 2026-07-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, New York, New York, United StatesPCAOB Form AP 2025-12-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $558K, sold $37K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-06-30
$271.7M$21.1M$41.8M$214.7M$1.5B$1.0B10-Q 2026-08-07
Q2 2026
2026-03-31
$221.8M-$4.1M$31.1M$184.9M$1.3B$1.0B10-Q 2026-05-05
Q1 2026
2025-12-31
$261.2M$44.1M$17.2M$201.3M$1.4B$1.1B10-Q 2026-02-05
Q4 2025
2025-09-30
$264.0M$26.4M$84.0M$225.5M$1.4B$1.1B10-K 2025-11-25
Q3 2025
2025-06-30
$295.5M$45.5M$81.2M$230.6M$1.5B$1.1B10-Q 2026-08-07
Q2 2025
2025-03-31
$259.0M$23.5M$31.8M$209.3M$1.5B$1.1B10-Q 2026-05-05
Q1 2025
2024-12-31
$261.9M$0-$5.3M$210.0M$1.5B$1.1B10-Q 2026-02-05
Q4 2024
2024-09-30
$286.1M$14.6M$26.6M$267.5M$1.6B$1.1B10-K 2025-11-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentDRS2021-07-15
Latest annual report10-K2025-11-25
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-08-07
Latest proxy
SCHEDULE 14A
DEFA14A2026-01-23

Source: SEC EDGAR submissions feed, 262 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.4%
1 month+4.2%
3 months+26.4%
Year to date-45.6%
1 year-55.2%
From 52-week high-55.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
CERSCerus Corporation$1.86-6.30%$375.6M
BWAYBrainsWay Ltd.$9.39-7.12%$376.8M
INFUInfuSystems Holdings Inc.$14.79+0.48%$296.3M
SIShoulder Innovations Inc.$20.45-1.16%$427.9M
TMCITreace Medical Concepts Inc.$4.42-16.13%$289.8M
MOBIMobia Medical Inc.$13.15-0.15%$438.3M
OFIXOrthofix Medical Inc. Common Stock (DE)$6.80-5.16%$277.2M
NPCENeuropace Inc.$7.97+5.42%$274.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier